|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.1400 - 0.1478|
|52 Week Range||0.0940 - 0.6045|
|Beta (5Y Monthly)||2.01|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
* The addressable market is estimated to be $80M CDN by 2022 * Tetra meets another key milestone before the end of the yearOTTAWA, ON / ACCESSWIRE / December 30, 2020 / Tetra Bio-Pharma Inc.
TORONTO, Dec. 22, 2020 /CNW/ - All Ontario doctors want this holiday season is your continued safety and good health.
* Tetra Provides Update on ARDS-003 * Tetra Eyes Global Sepsis MarketOTTAWA, ON / ACCESSWIRE / December 21, 2020 / Tetra Bio-Pharma Inc.